A citation-based method for searching scientific literature

Kiichi Nakahira, Jeffrey Adam Haspel, Vijay A K Rathinam, Seon-Jin Lee, Tamas Dolinay, Hilaire C Lam, Joshua A Englert, Marlene Rabinovitch, Manuela Cernadas, Hong Pyo Kim, Katherine A Fitzgerald, Stefan W Ryter, Augustine M K Choi. Nat Immunol 2011
Times Cited: 1727



Raúl Muñoz-Planillo, Peter Kuffa, Giovanny Martínez-Colón, Brenna L Smith, Thekkelnaycke M Rajendiran, Gabriel Núñez. Immunity 2013
Times Cited: 961




List of shared articles



Times cited

The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia.
Laura Urwanisch, Michela Luciano, Jutta Horejs-Hoeck. Int J Mol Sci 2021
2

1'-Acetoxychavicol acetate inhibits NLRP3-dependent inflammasome activation via mitochondrial ROS suppression.
Sophia P M Sok, Daisuke Ori, Ayana Wada, Haruna Okude, Takumi Kawasaki, Masatoshi Momota, Noor Hasima Nagoor, Taro Kawai. Int Immunol 2021
0

Assessing the Association of Mitochondrial Function and Inflammasome Activation in Murine Macrophages Exposed to Select Mitotoxic Tri-Organotin Compounds.
Gabrielle M Childers, Caroline A Perry, Barbara Blachut, Negin Martin, Carl D Bortner, Stella Sieber, Jian-Liang Li, Michael B Fessler, G Jean Harry. Environ Health Perspect 2021
2

Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.
Qingxue Xu, Bo Zhao, Yingze Ye, Yina Li, Yonggang Zhang, Xiaoxing Xiong, Lijuan Gu. J Neuroinflammation 2021
2

Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer.
Sonia Missiroli, Mariasole Perrone, Caterina Boncompagni, Chiara Borghi, Alberto Campagnaro, Francesco Marchetti, Gabriele Anania, Pantaleo Greco, Francesco Fiorica, Paolo Pinton,[...]. Cancers (Basel) 2021
3

p38 MAPK Activity Is Required to Prevent Hyperactivation of NLRP3 Inflammasome.
Jin Na Shin, Lang Rao, Youbao Sha, Elmoataz Abdel Fattah, Joseph Hyser, N Tony Eissa. J Immunol 2021
0

Antimycin A-induced mitochondrial dysfunction regulates inflammasome signaling in human retinal pigment epithelial cells.
Eveliina Korhonen, Maria Hytti, Niina Piippo, Kai Kaarniranta, Anu Kauppinen. Exp Eye Res 2021
0

AKT controls NLRP3 inflammasome activation by inducing DDX3X phosphorylation.
Xingchen Guo, Sheng Chen, Weiwei Yu, Zhexu Chi, Zhen Wang, Ting Xu, Jian Zhang, Danlu Jiang, Yuxian Guo, Hui Fang,[...]. FEBS Lett 2021
1

Increasing complexity of NLRP3 inflammasome regulation.
Julien Moretti, J Magarian Blander. J Leukoc Biol 2021
10


LCC18, a benzamide-linked small molecule, ameliorates IgA nephropathy in mice.
Shin-Ruen Yang, Kuo-Feng Hua, Akiko Takahata, Chung-Yao Wu, Chih-Yu Hsieh, Hsiao-Wen Chiu, Cheng-Hsu Chen, Debabrata Mukhopadhyay, Yusuke Suzuki, Shuk-Man Ka,[...]. J Pathol 2021
2

Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules.
Jin Kyung Seok, Han Chang Kang, Yong-Yeon Cho, Hye Suk Lee, Joo Young Lee. Front Immunol 2021
6

Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway.
Hélène Duez, Benoit Pourcet. Front Endocrinol (Lausanne) 2021
2

An update on the regulatory mechanisms of NLRP3 inflammasome activation.
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, Chihiro Sasakawa, Eun-Kyeong Jo. Cell Mol Immunol 2021
13

NLRP3 as a sensor of metabolism gone awry.
Emilia Neuwirt, Oliver Gorka, Benedikt S Saller, Christina J Groß, Tobias Madl, Olaf Groß. Curr Opin Biotechnol 2021
0